AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $423,398 | +68.2% | 17,107 | +56.1% | 0.00% | 0.0% |
| Q1 2023 | $251,659 | -65.2% | 10,956 | -57.4% | 0.00% | -66.7% |
| Q4 2022 | $722,526 | +48.7% | 25,731 | +49.9% | 0.00% | +50.0% |
| Q3 2022 | $486,000 | -78.3% | 17,168 | -83.0% | 0.00% | -83.3% |
| Q2 2022 | $2,243,000 | +124.1% | 101,191 | +194.4% | 0.01% | +200.0% |
| Q1 2022 | $1,001,000 | -28.6% | 34,372 | -19.4% | 0.00% | 0.0% |
| Q4 2021 | $1,401,000 | -68.7% | 42,629 | -58.8% | 0.00% | -87.9% |
| Q4 2020 | $4,483,000 | -2.5% | 103,454 | -21.3% | 0.03% | -46.8% |
| Q3 2020 | $4,599,000 | +426.2% | 131,406 | +433.5% | 0.06% | +181.8% |
| Q1 2020 | $874,000 | -83.7% | 24,630 | -78.1% | 0.02% | -31.2% |
| Q4 2019 | $5,361,000 | +514.8% | 112,265 | +542.4% | 0.03% | +300.0% |
| Q2 2019 | $872,000 | +226.6% | 17,477 | +202.3% | 0.01% | +166.7% |
| Q4 2018 | $267,000 | -88.6% | 5,782 | -81.0% | 0.00% | -89.3% |
| Q3 2018 | $2,347,000 | +173.5% | 30,434 | +198.9% | 0.03% | +154.5% |
| Q2 2018 | $858,000 | -12.2% | 10,181 | -40.4% | 0.01% | -35.3% |
| Q4 2017 | $977,000 | +251.4% | 17,088 | +310.7% | 0.02% | +240.0% |
| Q3 2017 | $278,000 | +4.5% | 4,161 | -19.4% | 0.01% | 0.0% |
| Q2 2017 | $266,000 | – | 5,161 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |